These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19763140)

  • 21. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 family members: similar biochemistry, different biology.
    Barbieri CE; Pietenpol JA
    Cancer Biol Ther; 2005 Apr; 4(4):419-20. PubMed ID: 15908776
    [No Abstract]   [Full Text] [Related]  

  • 23. p63: the phantom of the tumor suppressor.
    Finlan LE; Hupp TR
    Cell Cycle; 2007 May; 6(9):1062-71. PubMed ID: 17426453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
    Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
    Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
    Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and function in the p53 family.
    Arrowsmith CH
    Cell Death Differ; 1999 Dec; 6(12):1169-73. PubMed ID: 10637432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.
    Boominathan L
    PLoS One; 2010 May; 5(5):e10615. PubMed ID: 20485546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?
    Zawacka-Pankau J; Kostecka A; Sznarkowska A; Hedström E; Kawiak A
    Cell Cycle; 2010 Feb; 9(4):720-8. PubMed ID: 20160513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The p53 gene family.
    Kaelin WG
    Oncogene; 1999 Dec; 18(53):7701-5. PubMed ID: 10618710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The p53/p63/p73 family of transcription factors: overlapping and distinct functions.
    Levrero M; De Laurenzi V; Costanzo A; Gong J; Wang JY; Melino G
    J Cell Sci; 2000 May; 113 ( Pt 10)():1661-70. PubMed ID: 10769197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redox state of p63 and p73 core domains regulates sequence-specific DNA binding.
    Tichý V; Navrátilová L; Adámik M; Fojta M; Brázdová M
    Biochem Biophys Res Commun; 2013 Apr; 433(4):445-9. PubMed ID: 23501101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63 and p73 transcriptionally regulate genes involved in DNA repair.
    Lin YL; Sengupta S; Gurdziel K; Bell GW; Jacks T; Flores ER
    PLoS Genet; 2009 Oct; 5(10):e1000680. PubMed ID: 19816568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73.
    Stiewe T; Stanelle J; Theseling CC; Pollmeier B; Beitzinger M; Pützer BM
    J Biol Chem; 2003 Apr; 278(16):14230-6. PubMed ID: 12584188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The functional domains in p53 family proteins exhibit both common and distinct properties.
    Harms KL; Chen X
    Cell Death Differ; 2006 Jun; 13(6):890-7. PubMed ID: 16543939
    [No Abstract]   [Full Text] [Related]  

  • 37. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.
    Zhang L; Nie L; Maki CG
    Mol Cancer; 2006 Dec; 5():68. PubMed ID: 17150106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis for ASPP2 recognition by the tumor suppressor p73.
    Canning P; von Delft F; Bullock AN
    J Mol Biol; 2012 Nov; 423(4):515-27. PubMed ID: 22917970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional interplay between MDM2, p63/p73 and mutant p53.
    Stindt MH; Muller PA; Ludwig RL; Kehrloesser S; Dötsch V; Vousden KH
    Oncogene; 2015 Aug; 34(33):4300-10. PubMed ID: 25417702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of cadmium, cobalt and nickel on sequence-specific DNA binding of p63 and p73 in vitro and in cells.
    Adámik M; Bažantová P; Navrátilová L; Polášková A; Pečinka P; Holaňová L; Tichý V; Brázdová M
    Biochem Biophys Res Commun; 2015 Jan; 456(1):29-34. PubMed ID: 25446071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.